Showing results (161-170 of 225) with videos related to
Sort By:
Pageof 23
Stroke|January 11, 2019
AP-1 (Activated Protein-1) Transcription Factor JunD Regulates Ischemia/Reperfusion Brain Damage via IL-1β (Interleukin-1β)Candela Diaz-Cañestro, Martin F Reiner, Nicole R Bonetti, et al.Vascular Pharmacology|October 1, 2022
Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registriesGiulia Montrasio, Martin F Reiner, Andrea Wiencierz, et al.European Heart Journal. Quality of Care & Clinical Outcomes|January 25, 2020
Frailty to predict unplanned hospitalization, stroke, bleeding, and death in atrial fibrillationRebecca Gugganig, Stefanie Aeschbacher, Darryl P Leong, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 5, 2021
Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillationPhilipp Reddiess, Stefanie Aeschbacher, Pascal Meyre, et al.Atherosclerosis|April 29, 2021
Long-term dietary supplementation with plant-derived omega-3 fatty acid improves outcome in experimental ischemic strokeNicole R Bonetti, Luca Liberale, Alexander Akhmedov, et al.Atherosclerosis|April 23, 2021
Reduced adrenal stress response in patients on PCSK9 inhibitor therapySimon Meier, Marcel Frick, Michael Liu, et al.Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.Journal of the American Heart Association|April 12, 2021
Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial FibrillationAlexander P Benz, Stefanie Aeschbacher, Philipp Krisai, et al.Clinical Cardiology|November 10, 2020
Association of psychosocial factors with all-cause hospitalizations in patients with atrial fibrillationPascal B Meyre, Anne Springer, Stefanie Aeschbacher, et al.European Heart Journal|January 10, 2017
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardiumMartin F Reiner, Alexander Breitenstein, Erik W Holy, et al.Pageof 23